Found 79 results
Author Title Type [ Year(Desc)]
Filters: Author is Clemons, Traci E  [Clear All Filters]
2011
Klein, M. L., Francis, P. J., Ferris, F. L., Hamon, S. C., & Clemons, T. E.. (2011). Risk assessment model for development of advanced age-related macular degeneration. Arch Ophthalmol, 129(12), 1543-50. presented at the 2011 Dec. doi:10.1001/archophthalmol.2011.216
2012
Sallo, F. B., Peto, T., Egan, C., Wolf-Schnurrbusch, U. E. K., Clemons, T. E., Gillies, M. C., et al.. (2012). "En face" OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci, 53(10), 6145-52. presented at the 2012 Sep 14. doi:10.1167/iovs.12-10580
Sallo, F. B., Peto, T., Egan, C., Wolf-Schnurrbusch, U. E. K., Clemons, T. E., Gillies, M. C., et al.. (2012). The IS/OS junction layer in the natural history of type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci, 53(12), 7889-95. presented at the 2012 Nov 29. doi:10.1167/iovs.12-10765
2013
Niskopoulou, M., Balaskas, K., Leung, I., Sallo, F. B., Clemons, T. E., Bird, A. C., & Peto, T.. (2013). Is indocyanine green angiography useful for the diagnosis of macular telangiectasia type 2?. Br J Ophthalmol, 97(7), 946-8. presented at the 2013 Jul. doi:10.1136/bjophthalmol-2013-303118
Clemons, T. E., Gillies, M. C., Chew, E. Y., Bird, A. C., Peto, T., Wang, J. Jin, et al.. (2013). Medical characteristics of patients with macular telangiectasia type 2 (MacTel Type 2) MacTel project report no. 3. Ophthalmic Epidemiol, 20(2), 109-13. presented at the 2013 Apr. doi:10.3109/09286586.2013.766757
2014
Chamberlain, J. M., Okada, P., Holsti, M., Mahajan, P., Brown, K. M., Vance, C., et al.. (2014). Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial. JAMA, 311(16), 1652-60. presented at the 2014 Apr 23-30. doi:10.1001/jama.2014.2625
2015
Chew, E. Y., Clemons, T. E., Peto, T., Sallo, F. B., Ingerman, A., Tao, W., et al.. (2015). Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial. Am J Ophthalmol, 159(4), 659-666.e1. presented at the 2015 Apr. doi:10.1016/j.ajo.2014.12.013